FDA Cancels Manufacture Of Baby Powder By J&J In Mumbai Plant Over Quality Standards

The Food and Drug Administration (FDA) has cancelled manufacturing of baby powder by Johnson and Johnson (J&J)’s in Mumbai's Mulund plant on Thursday as samples were unable to meet the standard quality parameter.  The product may affect the health of the skin of the babies and has been recalled from the market. "For the safety of the public, we have cancelled the licence,” said an FDA official.